SCHEMBL16613

SCHEMBL16613

CC(C)N(C[C@@]1(c2ncc(C(O)(C(F)(F)F)C(F)(F)F)cn2)CN(S(=O)(=O)c2ccc(N)nc2)CCN1)S(C)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 18/20 0.47
GCKR Q14397 2/20 0.45
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17217 0.91 GCK (0.46) GCKGCKRCYP3A4CYP2D6
SCHEMBL17307 0.91 GCK (0.39) GCKGCKRCYP2D6
SCHEMBL23255 0.87 GCK (0.46) GCKGCKRCYP3A4CYP2D6
SCHEMBL17222 0.82 GCK (0.47) GCKGCKRCYP3A4CYP2D6
SCHEMBL17033 0.78 GCK (0.46) GCKGCKR
SCHEMBL17963 0.76 GCK (0.32) GCKCYP3A4CYP2D6
SCHEMBL16796 0.76 GCKR (0.65) GCKGCKR
SCHEMBL16816 0.74 GCK (0.31) GCK
SCHEMBL16561 0.73 GCK (0.38) GCKGCKRCYP2D6
SCHEMBL17404 0.71 RORC (0.32) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed